<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

true
true

CLAIM ID

8b0f6cc4

The United States Food and Drug Administration has approved EverlyWell's kit, the first COVID-19 nasal swab test kit for home use.

The announcement made by the U.S. Food and Drug Administration confirms that it has approved EverlyWell COVID-19 Test Home Collection Kit.

The announcement made by the U.S. Food and Drug Administration confirms that it has approved EverlyWell COVID-19 Test Home Collection Kit.The United States Food and Drug Administration(FDA) on 15 May 2020, granted emergency clearance to EverlyWell's kit, a COVID-19 testing kit that allows people to take a nasal sample at home and send it for testing.

On 16 May 2020, FDA issued an emergency use authorization(EUA) to American health firm Everlywell, Inc and it is currently the only authorized COVID-19 at-home sample collection kit for use with multiple authorized COVID-19 diagnostic tests. It mentioned that Everlywell’s kit is authorized to be used by people at home who have been screened using an online questionnaire that is reviewed by health care providers. Jeffrey Shuren, the director of the FDA’s Center for Devices and Radiological Health added that COVID-19 at-home collection kit also protects others from potential exposure.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.